These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10383605)

  • 1. Diabetic dyslipidaemia.
    Betteridge DJ
    Eur J Clin Invest; 1999 Jun; 29 Suppl 2():12-6. PubMed ID: 10383605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic dyslipidaemia: insights for optimizing patient management.
    Vergès B
    Curr Med Res Opin; 2005; 21 Suppl 1():S29-40. PubMed ID: 15811197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and dyslipidaemia.
    Schwartz SL
    Diabetes Obes Metab; 2006 Jul; 8(4):355-64. PubMed ID: 16776742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic dyslipidaemia.
    Betteridge DJ
    Diabetes Obes Metab; 2000 Mar; 2 Suppl 1():S31-6. PubMed ID: 11225757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic dyslipidaemia: current treatment recommendations.
    Best JD; O'Neal DN
    Drugs; 2000 May; 59(5):1101-11. PubMed ID: 10852642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies for diabetic dyslipidaemia.
    Bell DS; Al Badarin F; O'Keefe JH
    Diabetes Obes Metab; 2011 Apr; 13(4):313-25. PubMed ID: 21205114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of diabetic dyslipidaemia: where are we?
    Vergès B
    Diabetologia; 2015 May; 58(5):886-99. PubMed ID: 25725623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the management of diabetic dyslipidaemia.
    Taskinen MR
    Drugs; 1999; 58 Suppl 1():47-51; discussion 75-82. PubMed ID: 10576525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of Diabetic Dyslipidaemia.
    Filippatos T; Tsimihodimos V; Pappa E; Elisaf M
    Curr Vasc Pharmacol; 2017; 15(6):566-575. PubMed ID: 28155609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
    Goa KL; Barradell LB; Plosker GL
    Drugs; 1996 Nov; 52(5):725-53. PubMed ID: 9118820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidaemia in type 2 diabetes mellitus: bad for the heart.
    Katsiki N; Tentolouris N; Mikhailidis DP
    Curr Opin Cardiol; 2017 Jul; 32(4):422-429. PubMed ID: 28362666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic dyslipidaemia.
    Durrington PN
    Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Jul; 13(2):265-78. PubMed ID: 10761866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugar and fat, a recipe for disaster. New guidelines for the pharmacological management of diabetic dyslipidaemia.
    Tallis GA; Beng C; Popplewell P; Phillips P
    Aust Fam Physician; 1995 Sep; 24(9):1638-9, 1642-7, 1649. PubMed ID: 7487649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia.
    Al-Bahrani AI; Bakhiet CS; Bayoumi RA; Al-Yahyaee SA
    Diabetes Res Clin Pract; 2005 Jul; 69(1):44-51. PubMed ID: 15904989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.
    Keating GM; Ormrod D
    Drugs; 2002; 62(13):1909-44. PubMed ID: 12215067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid disorders in NIDDM: implications for treatment.
    Taskinen MR; Smith U
    J Intern Med; 1998 Nov; 244(5):361-70. PubMed ID: 9845851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of changes in antioxidant enzymes status in diabetic post menopausal group of women suffering from cardiovascular complications.
    Kumawat M; Sharma TK; Singh N; Ghalaut VS; Vardey SK; Sinha M; Kaushik GG
    Clin Lab; 2012; 58(3-4):203-7. PubMed ID: 22582492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.